Volume 77, Issue 1 , Pages 30-47, January 2011
Positron emission tomography and colorectal cancer
Abstract
Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality. Molecular imaging using positron emission tomography (PET) is now an integral part of multidisciplinary cancer care. In this review, we discuss the role of PET in CRC including well established indications in the assessment of recurrent disease and emerging applications such as initial staging, monitoring therapy efficacy and using PET for radiotherapy planning. With rapid advancement in imaging technology, we also discuss the future potential of combining PET and magnetic resonance imaging and the use of novel radiotracers.
Keywords: Positron emission tomography, PET, FDG, Colorectal cancer, Oncology, Therapy response
To access this article, please choose from the options below
PII: S1040-8428(10)00119-8
doi:10.1016/j.critrevonc.2010.04.011
Crown Copyright © 2010. Published by Elsevier Inc. All rights reserved.
Volume 77, Issue 1 , Pages 30-47, January 2011
